Neural block reduces hiot flashes in breast cancer survivors.
Performing stellate-ganglion block to interrupt the sympathetic nervous system pathways regulating temperature reduces the frequency of severe hot flashes and sleep disturbances in breast cancer survivors, according to a report published online May 15 in The Lancet Oncology.
Eugene G. Lipov, MD, of Advanced Pain Centers in Hoffman Estates, IL, and colleagues performed fluoroscopic-guided stellate-ganglion block at the anterolateral aspect of the C6 vertebra on the right side in 13 survivors of breast cancer (in remission) experiencing severe hot flashes and sleep dysfunction. Patients recorded hot flashes and night awakenings in a daily diary 1 week prior to the procedure and then weekly after the procedure for 12 weeks.
No adverse events were reported from the procedure, the researchers report. Mean number of hot flashes decreased from 79.4 per week at baseline to 49.9 per week during the 2 weeks after the procedure and continued to decline over time, reaching a plateau at 8.1 per week. Mean night awakenings also decreased from 19.5 per week at baseline and stabilized at 1.4 per week.
Lipov EG, Joshi JR, Sanders S, et al. Effects of stellate-ganglion block on hot flushes and night awakenings in survivors of breast cancer: a pilot study. Lancet Oncol. 2008;9:523-532 doi:10.1016/S1470-2045(08)70131-1.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More